CURRENT STATE OF POSTOPERATIVE RADIOTHERAPY OF LUNG CANCER

QR Code

CURRENT STATE OF POSTOPERATIVE RADIOTHERAPY OF LUNG CANCER

The problem adjuvant treatment of non-small cell lung cancer there are many unresolved questions, postoperative radiation therapy (PORT) is more controversial. Over the last decade there have been significant changes in the assessment of treatment results and treatment indications. Improvements in d...

Full description

Saved in:

Bibliographic Details
Main Author:	Yu. A. Ragulin
Format:	Article
Language:	Russian
Published:	Russian Academy of Sciences, Tomsk National Research Medical Center 2016-02-01
Series:	Сибирский онкологический журнал
Subjects:	non-small cell lung cancer, postoperative radiation therapy
Online Access:	https://www.siboncoj.ru/jour/article/view/225
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Impact of Postoperative Radiotherapy on Overall Survival in Patients with pN1 Non-Small Cell Lung Cancer
by: V. A. Solodkiy, et al.
Published: (2022-02-01)

Current problems of postoperative radiotherapy for non-small cell lung cancer
by: S. D. Trotsenko, et al.
Published: (2016-02-01)

Postoperative Cardiac Ischemic Complications in Lung Cancer Patients
by: O. A. Bolshedvorskaya, et al.
Published: (2019-11-01)

COMPARATIVE ANALYSIS OF THE RADIATION EXPOSURE ON THE TARGET AND CRITICAL ORGANS WITH 2D AND 3D PLANNING OF RADIATION THERAPY FOR LUNG CANCER
by: I. A. Gulidov, et al.
Published: (2016-02-01)

ANALYSIS OF THE QUALITY OF LIFE OF PATIENTS WITH INOPERABLE LUNG CANCER DURING RADIOTHERAPY AND PHOTODYNAMIC THERAPY
by: Yu. A. Ragulin, et al.
Published: (2020-01-01)

HIGH TOTAL DOSE RADIATION IMPROVES SURVIVAL OF PATIENTS WITH LOCALLY ADVANCED SMALL CELL LUNG CANCER: RESULTS OF SINGLE-CENTRAL RETROSPECTIVE ANALYSIS
by: Yu. V. Skripchak, et al.
Published: (2016-02-01)

CLINICAL SIGNIFICANCE OF THE DELAY IN STARTING SPECIAL TREATMENT FOR PATIENTS WITH SATGE III INOPERABLE NON-SMALL CELL LUNG CANCER: RESULTS OF STUDY AND LITERATURE REVIEW
by: Е. P. Solovyeva, et al.
Published: (2016-02-01)

UNCONVENTIONAL FRACTIONATION RADIOTHERAPY REGIMENS IN TREATMENT OF INOPERABLE LUNG CANCER
by: D. V. Gogolin, et al.
Published: (2019-09-01)

Nomogram for Predicting Postoperative Cardiopulmonary Complications in Non-Small Cell Lung Cancer Based on Systemic Inflammatory Markers: A Retrospective Study
by: He Z, et al.
Published: (2025-07-01)

ACCELEREATED HYPERFRACTIONATED WITH UNEVEN CRUSHING DAILY DOSE WITH CHEMORADIATION TREATMENT OF INOPERABLE NON-SMALL CELL LUNG CANCER.
by: D. V. Gogolin, et al.
Published: (2016-02-01)

Efficacy and Safety of First-Line Nivolumab Plus Ipilimumab in Patients with Postoperative Recurrent and Inoperable Non-Small Cell Lung Cancer: A Real-World Retrospective Observational Study
by: Yuhei Kurata, et al.
Published: (2025-05-01)

Analysis of Efficacy and Safety of Neoadjuvant Immunochemotherapy in Patients with Stage IB-IIIB Non-small Cell Lung Cancer
by: Zihao LI, et al.
Published: (2025-06-01)

Efficacy of immunotherapy remained in patients with recurrent/metastatic non‐small‐cell lung cancer after surgery with or without postoperative thoracic radiotherapy: a bi‐center retrospective study
by: Yuqi Wu, et al.
Published: (2025-07-01)

Research on the expression of E-cadherin in lung cancer tumors with different histological structures
by: E. N. Kolesnikov, et al.
Published: (2024-12-01)

LONG-TERM OUTCOMES OF INTRAOPERATIVE RADIATION THERAPY FOR NON-SMALL CELL LUNG CANCER
by: A. Yu. Dobrodeev, et al.
Published: (2019-06-01)

The role of tumor stem cells and the immune microenvironment in the pathogenesis of lung cancer: mechanisms of interaction and research prospects
by: D. A. Kharagezov, et al.
Published: (2024-12-01)

Radiotherapy after Neoadjuvant Immunochemotherapy in Unresectable Stage III Non‐Small Cell Lung Carcinoma: A Novel Therapeutic Approach?
by: Peizhu Wu, et al.
Published: (2025-06-01)

Detection of EGFR gene mutations for prescription of targeted drugs for non-small cell lung cancer
by: O. N. Pavlova, et al.
Published: (2024-04-01)

PHARMACOECONOMIC ASPECTS OF NON-SMALL CELL LUNG CANCER IMMUNOTHERAPY
by: A. V. Rudakova, et al.
Published: (2017-08-01)

EXPERIENCE WITH INTRAOPERATIVE CHEMOIMMUNOTHERAPY AFTER RADICAL OPERATIONS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER
by: P. A. Anistratov, et al.
Published: (2017-01-01)

Retrospective Analysis of the Timing of Radiotherapy Intervention After Induction Chemoimmunotherapy in Unresectable Locally Advanced Lung Squamous Cell Carcinoma
by: Zeng L, et al.
Published: (2025-07-01)

Salvage surgery after definitive chemoradiotherapy through VATS for an initial unresectable locally advanced lung cancer: an alternative consolidative modality to radiotherapy?
by: Hsuan-Hsuan Yu, et al.
Published: (2021-06-01)

COMPARISON OF CONVENTIONAL RADIATIOTHERAPY AND ACCELERATED HYPERFRACTIONATED RADIATIOTHERAPY IN CHEMORADIATION TREATMENT FOR SMALL CELL LUNG CANCER
by: I. A. Gulidov, et al.
Published: (2016-02-01)

Assessment of efficacy, safety, and prognostic/predictive factors of nintedanib/docetaxel in advanced/recurrent non–small cell lung cancer post-immunotherapy and chemotherapy: A Galician Lung Cancer Group study
by: Natalia Fernández Núñez, et al.
Published: (2025-01-01)

Small-cell lung cancer
by: Nicolay G. Bakhmutsky, et al.
Published: (2017-12-01)

THE ROLE OF RADIOTHERAPY DELAY IN THE CHEMORADIATION TREATMENT FOR STAGE III INOPERABLE NON-SMALL CELL LUNG CANCER
by: E. P. Solov’eva, et al.
Published: (2016-02-01)

Quality of life and influencing factors of non-small cell lung cancer patients treated with first-line targeted therapy in Vietnam: A study using the EORTC QLQ-C30 scale
by: Chinh Van Nguyen, et al.
Published: (2025-07-01)

Regional Chemotherapy Infusion Via the Bronchial Artery in Combined Treatment of Non-Small Cell Lung Cancer
by: K. Sh. Gantsev, et al.
Published: (2020-11-01)

Impact of metabolic and nutritional disorders on the synergy between radiotherapy and immunotherapy in non-small-cell lung cancer
by: Haiyan Chen, et al.
Published: (2025-05-01)

HYPERTHERMIA IN TREATMENT OF NON-SMALL CELL LUNG CANCER
by: А. Yu. Dobrodeev, et al.
Published: (2016-02-01)

Postoperative myocardial infarction in lung cancer patients with: incidence rate, clinical features, prognostic factors
by: O. A. Bolshedvorskaya, et al.
Published: (2020-12-01)

Adebrelimab in Small Cell Lung Cancer: From Current Advances to Emerging Combination Strategy and Challenge
by: Yang H, et al.
Published: (2025-05-01)

Prediction of fatal cardiovascular events in patients with newly diagnosed non-small cell lung cancer
by: A. A. Filippov, et al.
Published: (2024-08-01)

Analysis of safety of postoperative accelerated hypofractionated radiotherapy for patients with stage I-IIIA breast cancer
by: G. V. Afonin, et al.
Published: (2020-04-01)

PHOTODYNAMIC THERAPY FOR LUNG CANCER: MAJOR INDICATIONS
by: Yu. A. Ragulin, et al.
Published: (2016-10-01)

The estimation of chemotherapeutic pathomorphosis of non-small cell lung cancer.
by: Sukhoversha O.A., et al.
Published: (2007-01-01)

Stereotactic fractionated radiotherapy for multiple brain metastasis treated with single isocenter multitargeted approach: a case report
by: Siddharth Arora, et al.
Published: (2025-06-01)

Frequency and Prognostic Impact of Local Ablation Therapy for Oligoprogression in Non‐Small Cell Lung Cancer
by: Daisuke Morinaga, et al.
Published: (2025-07-01)

ANTIBODIES TO BENZO[A]PYRENE IN SERUM OF PATIENTS WITH NON-SMALL CELL LUNG CANCER
by: E. G. Polenok, et al.
Published: (2012-05-01)

Lung Adenocarcinoma With Extensive Vascular Invasion and Retinal Metastasis: A Case Report
by: Bassem Alhariri, et al.
Published: (2025-06-01)